Log in to save to my catalogue

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in v...

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in v...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3654969

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β

About this item

Full title

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2013-05, Vol.13 (1), p.224-224

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive and associated with poor prognosis. Basic research to develop new treatment regimens is critically needed.
The effects of imatinib mesylate on MPNSTs were examined in six human MPNST cell lines and in a xenograft mouse model.
The results showed expression of platelet-deri...

Alternative Titles

Full title

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3654969

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3654969

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/1471-2407-13-224

How to access this item